vasodilator agents

52
Cardiovascular Pharmacology Vasodilator Agents Department of Pharmacology College of Medicine, UoD

Upload: shahad-algarni

Post on 21-Aug-2015

62 views

Category:

Documents


6 download

TRANSCRIPT

Page 1: Vasodilator agents

Cardiovascular Pharmacology

Vasodilator Agents

Department of PharmacologyCollege of Medicine, UoD

Page 2: Vasodilator agents

Learning Objectives

After participating in this session, it is expected that students will be able to:

• Describe The Mechanism Of Action Of Some Vasodilator Drugs (Eg Nitrites/Nitrates, Hydralazine, Alpha-adrenoceptor Antagonists)

• Discuss The Basis For Their Use In The Treatment Of Angina And/Or Heart Failure

• Describe Their Pharmacokinetics And Their Adverse Effects

Vasodilator Agents

21:20

2

Page 3: Vasodilator agents

Cardiovascular Pharmacology Vasodilator agents

Inotropic agents

Lipid lowering drugs

Antiarrhythmic agents

Next yearDiuretics (renal disorders)

Treatment of Hypertension 1

Treatment of Hypertension 2

Treatment of Anemia

Anticoagulant drugs

21:20

Vasodilator Agents 3

Page 4: Vasodilator agents

• (Ischaemic heart disease; coronary artery disease)• Includes :

Acute myocardial infarction (heart attack)o Death congestive heart failure

Angina: radiating chest paino (Coronary spasm exertional) need to decrease

metabolic demands on heart Cardiac arrhythmias o Artrial/ventricular altered rhythm/death

• Major underlying causes: Atherosclerosis Hypertension (LVH)

Coronary Heart Disease

21:20

Vasodilator Agents 4

Page 5: Vasodilator agents

Fig 13.22

21:20

Vasodilator Agents 5

Page 6: Vasodilator agents

• Coronary arteries arise above aortic valve, fill in diastole

• Arteries are external to myocardium muscle hypertrophy- vessels are stretched.

• Arteries are small calibre; any narrowing- poor flow• Only some degree of collateral supply• Sub-endocardial is vulnerable zone

21:20

Vasodilator Agents 6

Page 7: Vasodilator agents

Vasodilatation….

Blood Pressure = Cardiac Output x Peripheral Resistance

Artery Diameter

Vascular Smooth MuscleContraction/Relaxation

Rhythm Pumping

Heart

21:20

Vasodilator Agents 7

Page 8: Vasodilator agents

Resting Diameter, Normal BP

BP

Vasodilate Diameter

Peripheral Resistance

BP

Vasoconstrict Diameter

Peripheral Resistance

21:20

Vasodilator Agents 8

Page 9: Vasodilator agents

Mean Arterial Blood Pressure = MAP

MAP = CO x TPR

TPR? 4 1/r

Blood pressure changes across the vascular tree

21:20

Vasodilator Agents 9

Page 10: Vasodilator agents

Effector: Autonomic NSC

entr

al N

erv

ou

s S

yst

emSympathetic system

ACh

Parasympathetic system

ACh

ACh adrenal medulla

Somatic efferent system

21:20

Vasodilator Agents 10

Page 11: Vasodilator agents

Effector: Autonomic NSC

entr

al N

erv

ou

s

Syst

emSympathetic system

ACh

Parasympathetic system

ACh

ACh adrenal medulla

Somatic efferent system

NA

(NA)Adren

ACh

ACh

M

N

21:20

Vasodilator Agents 11

Page 12: Vasodilator agents

Endothelial Cells

Vascular Smooth

Muscle(also adrenergics…)

Vasodilators- Nitric Oxide- Prostacyclin- EDHF

Vasoconstrictors- Endothelin- Angiotensin- Thromboxane A2

Vasoconstriction Vasorelaxation

21:20

Vasodilator Agents 12

Page 13: Vasodilator agents

Normal blood vessela

Atherosclerotic plaque- Impaired blood flow

Vasodilate to improve blood flow

21:20

Vasodilator Agents 13

Page 14: Vasodilator agents

A 74-year-old man presents with a history of anterior chest pressure whenever he walks more than one block. The chest discomfort is diffuse, and he cannot localize it; sometimes it radiates to his lower jaw. The discomfort is more severe when he walks after meals but is relieved within 5–10 minutes when he stops walking. Assuming that a diagnosis of stable effort angina is correct, what medical treatments should be implemented to reduce the acute pain of an attack and to prevent future attacks?

Case Study

21:20

Vasodilator Agents 14

Page 15: Vasodilator agents

Commonly Used Antihypertensive Drugs

Angiotensin converting enzyme inhibitors & Angiotensin receptor blockers

Beta receptor blockers

Calcium channel blockers

Diuretics (thiazides, loop, K+ sparing)

Nitrovasodilators

21:20

Vasodilator Agents 15

Page 16: Vasodilator agents

Commonly Used Antianginal Drugs

Angiotensin converting enzyme inhibitors & Angiotensin receptor blockers

Beta receptor blockers

Calcium channel blockers

Diuretics (thiazides, loop, K+ sparing)

Nitrovasodilators

Digoxin

21:20

Vasodilator Agents 16

Page 17: Vasodilator agents

Angina PectorisSymptoms:

• Pain, severe, crushing, sub-sternal, may radiate + Shortness of breath

• lasts a few minutes (usually relieved by rest &/or sublingual nitrate)

Causes:

• Coronary artery disease, coronary vasospasm due to insufficient O2 supply to heart

• i.e. imbalance: myocardial O2 demand >> O2 supply

Urgent medical attention required for:

• Worsening angina (unstable angina)

• Chest pain lasting more than a few minutes

21:20

Vasodilator Agents 17

Page 18: Vasodilator agents

Types• Chronic, stable angina (atherosclerosis +/++)

Caused by exercise, coronary artery disease

• Unstable angina (atherosclerosis +++)

Unpredictable, thrombi formation

• Variant (vasospastic) angina (no atherosclerosis)

Spasm of coronary artery

Risk factors:

• Hypertension, cholesterol, smoking etc

Precipitated by:

• Exertion, cold, stress, large meals

21:20

Vasodilator Agents 18

Page 19: Vasodilator agents

• (Ischaemic heart disease; coronary artery disease)• Includes :

Acute myocardial infarction (heart attack)o Death congestive heart failure

Angina: radiating chest paino (Coronary spasm exertional) need to decrease

metabolic demands on heart Cardiac arrhythmias o Artrial/ventricular altered rhythm/death

• Major underlying causes: Atherosclerosis Hypertension (LVH)

Coronary Heart Disease

21:20

Vasodilator Agents 19

Page 20: Vasodilator agents

Atherosclerotic Lesions In Blood Vessel

Unstable rupture? AMI / stroke

Deposition of plaque (includes lipids) in the walls of medium / largeArteries reduces internal diameter

21:20

Vasodilator Agents 20

Page 21: Vasodilator agents

21:20

Vasodilator Agents 21

Page 22: Vasodilator agents

Treatment of Angina

• Modification of risk factors: smoking, obesity, hypertension, hyperlipidemia, diabetes

• Nonpharmacological: Surgery/angioplasty/stents

• Drug treatment

21:20

Vasodilator Agents 22

Page 23: Vasodilator agents

Balloon Angioplasty

21:20

Vasodilator Agents 23

Page 24: Vasodilator agents

Coronary Artery Bypass Graft

(CABG)

21:20

Vasodilator Agents 24

Page 25: Vasodilator agents

Human saphenous vein

Neointima

21:20

Vasodilator Agents 25

Page 26: Vasodilator agents

Drugs for Angina: Mechanisms• coronary perfusion to oxygen supply

• metabolic demand

• Combination of both

Determinants of myocardial oxygen requirement:

• heart rate

• contractility

• ventricular volume

• arterial pressure

VenodilatationCO oxygen consumption

Arterial dilatation peripheral resistance oxygen consumption

coronary dilatation increase oxygen supply

21:20

Vasodilator Agents 26

Page 27: Vasodilator agents

Nitrates

• Result in release of nitric oxide in vascular smooth muscle with consequent vasodilatation, particularly in veins (smooth muscle relaxants)

• They have no effect on cardiac or skeletal muscle

21:20

Vasodilator Agents 27

Page 28: Vasodilator agents

Mechanism of action of Nitric OxideEndothelial cell

L-arginine L-citrulline

NOS

NO

NO

Vascular smooth muscle

guanylate cyclase

cGMP

RELAXATION

Ca2+

21:20

Vasodilator Agents 28

Page 29: Vasodilator agents

Nitrovasodilators can donate NO from their structureEndothelial cell

L-arginine L-citrulline

NOS

NO

NO

Vascular smooth muscle

guanylate cyclase

cGMP

RELAXATION

Glyceryl trinitrate (GTN)nitrates

Ca2+

21:20

Vasodilator Agents 29

Page 30: Vasodilator agents

Nitrates: Mechanism in Angina

• Venous dilatation reduces venous pressure and pre-load, with consequent fall in cardiac oxygen consumption

• Arteriolar dilatation reduces peripheral resistance and after-load with consequent fall in cardiac oxygen consumption

• Coronary dilatation- e.g. variant angina

Limitation:

• blood pressure is associated with a reflex tachycardia tendency to increase cardiac oxygen consumption

21:20

Vasodilator Agents 30

Page 31: Vasodilator agents

Additional Benefit of Nitrate Over Some Vasodilators

21:20

Vasodilator Agents 31

Page 32: Vasodilator agents

Nitrates - Metabolism

• Large hepatic “first pass” metabolism (eg. > 90%)

• Nitroglycerin inactive orally

(give sublingually or transdermally)

21:20

Vasodilator Agents 32

Page 33: Vasodilator agents

Examples of Nitrates

Nitroglycerin (glyceryl trinitrate):

• Sub-lingual (tablet or spray, lasts<30 min)

• Transdermal (patch or ointment, < 24 hr)

Isosorbide dinitrate:

• Sub-lingual (lasts < 2 hr)

• Oral (lasts < 6 hr)

21:20

Vasodilator Agents 33

Page 34: Vasodilator agents

Use of Sublingual Nitroglycerin

• Treatment of acute attack of angina

• Immediate prophylaxis

• If using tablets rather than spray, they must be kept in a closed non-plastic container as they lose activity (volatile)

21:20

Vasodilator Agents 34

Page 35: Vasodilator agents

Nitrates - adverse effects

• Hypotension (fainting): should not be combined with Viagra or similar drugs

• Tachycardia

• Headache

• Flushing

Nitrates – tolerance:

• Develops after continual exposure

• A nitrate-free period (e.g. for 8 hours per 24 hours when using transdermal patches) reduces tolerance

21:20

Vasodilator Agents 35

Page 36: Vasodilator agents

Sildenafil (VIAGRA)• PDE5 inhibitor (many isoforms)• Potentiate ‘NO donours’ BP• Contraindicated with nitrates

21:20

Vasodilator Agents 36

Page 37: Vasodilator agents

Deaths Associated with Sildenafil Therapy in the United States. From: Lue: N Engl J Med, Volume 342(24).June 15, 2000.1802-1813

Side Effects- Mainly CVS

21:20

Vasodilator Agents 37

Page 38: Vasodilator agents

Calcium Contraction

21:20

Vasodilator Agents 38

Page 39: Vasodilator agents

Coronary Angiogram

before after Ca2+ channel blocker

This type of response could occur in variant angina

21:20

Vasodilator Agents 39

Page 40: Vasodilator agents

Calcium Antagonist

Cardiac Effects

BP HR TPR

Verapamil +++

Diltiazem ++ /-

NifedipineAmlodipinne

+ ↑↑

21:20

Vasodilator Agents 40

Blockade of L-type (voltage operated) Ca2+ channels;Reduces Ca2+ entry into vascular* / cardiac cells (not SkM)

Therefore, reduction in intracellular Ca2+

• reduce venous pressure (preload)• reduce arteriolar pressure (afterload)* Reflex

Page 41: Vasodilator agents

Ca Channel BlockersCause: • Vasodilatation (arterial > venous)

• Reduced cardiac contractility & reduced atrio-ventricular conduction (verapamil > diltiazem > nifedipine)

Indications:Angina, hypertension, tachyarrhythmias (SVT)

Angina:TPR & cardiac work

reduce cardiac oxygen demand

• coronary vasodilation can help variant angina (angina due to vessel spasm, not fixed block)

21:20

Vasodilator Agents 41

Page 42: Vasodilator agents

Ca Blockers: Adverse Effects

• Cardiac depression, bradycardia

• (Contraindicated in heart failure)

• Flushing, edema, dizziness, headache

• Constipation, nausea

Contraindications:• heart failure

• -blockers (with verapamil or diltiazem)

21:20

Vasodilator Agents 42

Page 43: Vasodilator agents

-Adrenoceptor Antagonists

• Decrease sympathetic drive to heart

CO ( HR); ()TPR Inhibit renin release ( angiotensin II) Reduced sympathetic outflow from central

nervous system (if lipid soluble)

ACh NAsympathetic NS

b1

heart

21:29

Vasodilator Agents 43

Page 44: Vasodilator agents

Uses of β-blockerse.g. propranolol (Inderal) - nonselective 1 & 2 antag

atenolol (Tenormin), metoprolol (Betaloc)- 1 selective antag

• Hypertension

• Angina

• Post myocardial infarct

• Arrhythmias

• Clinically stable heart failure (carvedilol)

• Beware contraindications….

21:20

Vasodilator Agents 44

Page 45: Vasodilator agents

Uses of β-blockerse.g. propranolol- nonselective 1 & 2 antag

atenolol, metoprolol- 1 selective antag

Angina:

cardiac oxygen demand

heart rate increases coronary artery perfusion time during diastole (relaxation phase) oxygen supply to the heart

21:20

Vasodilator Agents 45

Page 46: Vasodilator agents

b-Blockers: Adverse Effects

Respiratory: bronchoconstriction (2 effect)

Cardiovascular: Decreased heart contractility, Bradycardia, Atrio-ventricular block, Exercise intolerance, Claudication, Impotence, beware sudden withdrawal

Brain (if lipid soluble): depression, sedation, sleep problems

Diabetes: exacerbate & mask hypoglycemia

21:20

Vasodilator Agents 46

Page 47: Vasodilator agents

Variant Angina• Nitrates and calcium antagonists also reduce

coronary artery spasm in variant angina (not due to fixed block)

• In addition, beta blockers, by slowing heart rate, can increase coronary artery perfusion time

• Variant angina: beware b-blockersUnstable Angina

• Dipyridamol : adenosinevasodilator (variant)antiplatelet (unstable)

• Aspirin - antiplatelet

21:20

Vasodilator Agents 47

Page 48: Vasodilator agents

Points About Anti-anginal Drugs• Chest pain lasting more than a few minutes or

worsening (unstable) angina require urgent medical attention

• Drugs can be used for stable angina

• Nitrates can be used prophylactically (e.g. before attempting exercise)

• Beta-blockers reduce exercise ability & can cause bronchoconstriction

• Anti-anginal drugs can cause hypotension and faintness: to reduce this, patients can lie down whilst taking nitrates (especially on starting them)

21:20

Vasodilator Agents 48

Page 49: Vasodilator agents

A 74-year-old man presents with a history of anterior chest pressure whenever he walks more than one block. The chest discomfort is diffuse, and he cannot localize it; sometimes it radiates to his lower jaw. The discomfort is more severe when he walks after meals but is relieved within 5–10 minutes when he stops walking. Assuming that a diagnosis of stable effort angina is correct, what medical treatments should be implemented to reduce the acute pain of an attack and to prevent future attacks?

Case Study

21:20

Vasodilator Agents 49

Page 50: Vasodilator agents

(Esomeprazole)

(Spironolactone)

FK’s current medications(Aug 2010):

Pharmacology in the wild

Oct 2013Transderm Nitro

21:20

Vasodilator Agents 50

Page 51: Vasodilator agents

Answer

• The case described is typical of stable atherosclerotic angina. Treatment of acute episodes should include sublingual tablets or sprayed nitroglycerin, 0.4–0.6 mg. Relief of discomfort within 2–4 minutes can be expected. If anginal episodes are frequent, or to prevent episodes of angina, a blocker such as metoprolol should be tried first. If contraindications to the use of a blocker are present, a medium- to long-acting calcium channel blocker such as verapamil, diltiazem, or amlodipine is likely to be effective.

21:20

Vasodilator Agents 51

Page 52: Vasodilator agents

21:20

Vasodilator Agents 52